Get started
222

KOREA ARLICO PHARM CO.,LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

260660 chart


Full chart

Key stats


Market capitalization
‪51.94 B‬ KRW
Dividend yield (indicated)
3.77%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−500 KRW
Net income (FY)
‪3.06 B‬ KRW
Revenue (FY)
‪187.15 B‬ KRW
Shares float
‪8.70 M‬
Beta (1Y)
0.42

Employees


Employees (FY)
225
Change (1Y)
+27 +13.64%
Revenue / Employee (1Y)
‪831.80 M‬ KRW
Net income / Employee (1Y)
‪13.60 M‬ KRW

About KOREA ARLICO PHARM CO.,LTD.


Sector
Health Technology
CEO
Hang-Gu Lee
Headquarters
Seoul
Website
arlico.co.kr
Founded
1992
ISIN
KR7260660006
FIGI
BBG00JNHR8N3
Korea Arlico Pharm Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include chlorhexidine, smol, mudis, emmao plus, and acrason cream, eldosin capsule, arlicough, conazine, and mosarin tabs, and others. The company was founded December 28, 1992 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 260660 is 3,755 KRW — it has increased by 21.62% in the past 24 hours. Watch KOREA ARLICO PHARM CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KOREA ARLICO PHARM CO.,LTD. stocks are traded under the ticker 260660.
260660 stock has risen by 22.34% compared to the previous week, the month change is a 21.26% rise, over the last year KOREA ARLICO PHARM CO.,LTD. has showed a −34.24% decrease.
260660 reached its all-time high on Feb 14, 2018 with the price of 21,175 KRW, and its all-time low was 3,290 KRW and was reached on Nov 15, 2024. View more price dynamics on 260660 chart.
See other stocks reaching their highest and lowest prices.
260660 stock is 28.35% volatile and has beta coefficient of 0.42. Track KOREA ARLICO PHARM CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is KOREA ARLICO PHARM CO.,LTD. there?
Today KOREA ARLICO PHARM CO.,LTD. has the market capitalization of ‪51.72 B‬, it has increased by 0.73% over the last week.
Yes, you can track KOREA ARLICO PHARM CO.,LTD. financials in yearly and quarterly reports right on TradingView.
260660 net income for the last quarter is ‪1.08 B‬ KRW, while the quarter before that showed ‪−2.81 B‬ KRW of net income which accounts for 138.35% change. Track more KOREA ARLICO PHARM CO.,LTD. financial stats to get the full picture.
Yes, 260660 dividends are paid annually. The last dividend per share was 130.00 KRW. As of today, Dividend Yield (TTM)% is 3.77%. Tracking KOREA ARLICO PHARM CO.,LTD. dividends might help you take more informed decisions.
KOREA ARLICO PHARM CO.,LTD. dividend yield was 2.28% in 2023, and payout ratio reached 63.76%. The year before the numbers were 1.98% and 24.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 13, 2024, the company has 225.00 employees. See our rating of the largest employees — is KOREA ARLICO PHARM CO.,LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOREA ARLICO PHARM CO.,LTD. EBITDA is ‪−2.79 B‬ KRW, and current EBITDA margin is 4.19%. See more stats in KOREA ARLICO PHARM CO.,LTD. financial statements.
Like other stocks, 260660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOREA ARLICO PHARM CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOREA ARLICO PHARM CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOREA ARLICO PHARM CO.,LTD. stock shows the sell signal. See more of KOREA ARLICO PHARM CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.